A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

被引：0
|
作者：
Kei Hosoda
Mizutomo Azuma
Chikatoshi Katada
Kenji Ishido
Masahiro Niihara
Hideki Ushiku
Mikiko Sakuraya
Marie Washio
Takuya Wada
Akinori Watanabe
Hiroki Harada
Satoshi Tanabe
Wasaburo Koizumi
Keishi Yamashita
Naoki Hiki
机构：
[1] Kitasato University School of Medicine,Department of Upper Gastrointestinal Surgery
[2] Kitasato University School of Medicine,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Locally advanced esophagogastric junction cancer; Docetaxel; Oxaliplatin; S-1; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1097
页数：7
相关论文
共 50 条
  • [31] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Sato, Hirohiko
    Shimada, Mitsuo
    Kurita, Nobuhiro
    Iwata, Takashi
    Yoshikawa, Kozo
    Higashigima, Jun
    Chikakio, Motoya
    Kashihara, Hideya
    Takasu, Chie
    Matsumoto, Noriko
    Eto, Shozo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 543 - 548
  • [32] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Hirohiko Sato
    Mitsuo Shimada
    Nobuhiro Kurita
    Takashi Iwata
    Kozo Yoshikawa
    Jun Higashigima
    Motoya Chikakio
    Hideya Kashihara
    Chie Takasu
    Noriko Matsumoto
    Shozo Eto
    International Journal of Clinical Oncology, 2015, 20 : 543 - 548
  • [33] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
    Zhichao Jiang
    Yibin Xie
    Wen Zhang
    Chunxia Du
    Yuxin Zhong
    Yuelu Zhu
    Liming Jiang
    Lizhou Dou
    Kang Shao
    Yongkun Sun
    Qi Xue
    Yantao Tian
    Shugeng Gao
    Dongbing Zhao
    Aiping Zhou
    Gastric Cancer, 2024, 27 : 571 - 579
  • [34] Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer
    Moehler, Markus
    Mahlberg, Rolf
    Heinemann, Volker
    Obermannova, Radka
    Kubala, Eugen
    Melichar, Bohuslav
    Weinmann, Arndt
    Scigalla, Paul
    Tesarova, Marietta
    Janda, Petr
    Hedouin-Biville, Fabienne
    Mansoor, Wasat
    GASTRIC CANCER, 2017, 20 (02) : 358 - 367
  • [35] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
    Jiang, Zhichao
    Xie, Yibin
    Zhang, Wen
    Du, Chunxia
    Zhong, Yuxin
    Zhu, Yuelu
    Jiang, Liming
    Dou, Lizhou
    Shao, Kang
    Sun, Yongkun
    Xue, Qi
    Tian, Yantao
    Gao, Shugeng
    Zhao, Dongbing
    Zhou, Aiping
    GASTRIC CANCER, 2024, 27 (03) : 571 - 579
  • [36] Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)
    Satake, Hironaga
    Miki, Akira
    Kondo, Masato
    Kotake, Takeshi
    Okita, Yoshihiro
    Hatachi, Yukimasa
    Yasui, Hisateru
    Imai, Yukihiro
    Ichikawa, Chihiro
    Murotani, Kenta
    Hashida, Hiroki
    Kobayashi, Hiroyuki
    Kotaka, Masahito
    Kato, Takeshi
    Kaihara, Satoshi
    Tsuji, Akihito
    ESMO OPEN, 2017, 2 (01)
  • [37] Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
    Takahashi, I
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Oki, E
    Watanabe, M
    Baba, H
    Maehara, Y
    ONCOLOGY REPORTS, 2006, 15 (04) : 849 - 854
  • [38] Phase I/II study of new combination chemotherapy with docetaxel and S-1 for advanced gastric cancer
    Hyodo, Ichinosuke
    Yamaguchi, Kensei
    Saitoh, Soh
    Takiuchi, Hiroya
    Miyata, Yoshinori
    Sakata, Yuh
    ANNALS OF ONCOLOGY, 2004, 15 : 246 - 246
  • [39] Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer
    Markus Moehler
    Rolf Mahlberg
    Volker Heinemann
    Radka Obermannová
    Eugen Kubala
    Bohuslav Melichar
    Arndt Weinmann
    Paul Scigalla
    Marietta Tesařová
    Petr Janda
    Fabienne Hédouin-Biville
    Wasat Mansoor
    Gastric Cancer, 2017, 20 : 358 - 367
  • [40] Neoadjuvant serplulimab in combination with concurrent chemoradiotherapy for locally advanced, resectable esophagogastric junction adenocarcinoma
    Ge, Yuping
    Zhao, Lin
    Kang, Weiming
    Yan, Junfang
    Wang, Xiang
    Li, Ningning
    Ye, Xin
    You, Yan
    Gao, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345